| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050887615 |
| P356 | DOI | 10.1186/S40364-015-0049-9 |
| P932 | PMC publication ID | 4559887 |
| P698 | PubMed publication ID | 26346508 |
| P5875 | ResearchGate publication ID | 281626848 |
| P50 | author | Jean Jacques Noubiap | Q47157965 |
| Mickael Essouma | Q85276966 | ||
| P2860 | cites work | Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials | Q22252667 |
| Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators | Q26864064 | ||
| Asymmetric dimethyarginine as marker and mediator in ischemic stroke | Q26864318 | ||
| HDL-Associated Paraoxonase 1 as a Bridge between Postmenopausal Osteoporosis and Cardiovascular Disease | Q27004783 | ||
| The role of the microbiome in rheumatic diseases | Q28284835 | ||
| Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data | Q31005025 | ||
| Quo vadis: whither homocysteine research? | Q33457245 | ||
| Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment | Q33943374 | ||
| Notable epigenetic role of hyperhomocysteinemia in atherogenesis | Q34143826 | ||
| A pivotal role of vitamin B9 in the maintenance of regulatory T cells in vitro and in vivo | Q34171642 | ||
| Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 | ||
| A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases | Q34392922 | ||
| The intestinal absorption of folates | Q34403349 | ||
| Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america | Q34495257 | ||
| The intestine plays a substantial role in human vitamin B6 metabolism: a Caco-2 cell model | Q34559157 | ||
| Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis | Q44668779 | ||
| Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. | Q45998671 | ||
| Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Q46003173 | ||
| Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis. | Q46090014 | ||
| The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis | Q46212253 | ||
| Severe atherosclerosis in rheumatoid arthritis and hyperhomocysteinemia: is there a link? | Q46611001 | ||
| Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis | Q46723341 | ||
| Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia | Q49015201 | ||
| Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. | Q53027142 | ||
| Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial | Q56786477 | ||
| Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis | Q57169251 | ||
| Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency | Q59504358 | ||
| Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials | Q61890982 | ||
| Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis | Q63184843 | ||
| Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
| Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis | Q83205796 | ||
| Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study | Q84840737 | ||
| Folic acid supplementation with and without vitamin B6 and revascularization risk: a meta-analysis of randomized controlled trials | Q87161041 | ||
| Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis | Q34586496 | ||
| Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. | Q34995526 | ||
| Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL? | Q35049058 | ||
| Epigenetics in the pathogenesis of rheumatoid arthritis | Q35102634 | ||
| Lipid peroxidation-mediated inflammation promotes cell apoptosis through activation of NF-κB pathway in rheumatoid arthritis synovial cells | Q35110153 | ||
| The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | Q35135831 | ||
| Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 | ||
| Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis | Q35548424 | ||
| Immune activation in the small intestine in patients with rheumatoid arthritis. | Q35553400 | ||
| Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. | Q35667122 | ||
| Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders | Q35864204 | ||
| Rheumatoid arthritis: a disease associated with accelerated atherogenesis | Q36220303 | ||
| Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis | Q36326701 | ||
| The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis | Q36434130 | ||
| Hyperhomocysteinemia, inflammation and autoimmunity | Q36888166 | ||
| Methotrexate catabolism to 7-hydroxymethotrexate in rheumatoid arthritis alters drug efficacy and retention and is reduced by folic acid supplementation | Q36948402 | ||
| Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases? | Q36986256 | ||
| Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. | Q37306085 | ||
| Homocysteine and peripheral arterial disease: systematic review and meta-analysis | Q37533752 | ||
| Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. | Q37583248 | ||
| Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials | Q37632526 | ||
| Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. | Q37691140 | ||
| Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials | Q37972457 | ||
| Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis | Q38011260 | ||
| Endothelial dysfunction in joint disease | Q38190775 | ||
| Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial | Q38414941 | ||
| Prevention of cardiovascular disease in rheumatoid arthritis | Q38539171 | ||
| Absorption and Transport of Cobalamin (Vitamin B12) | Q40137611 | ||
| Effectiveness of B vitamins on the control of hypertension and stroke events of SHRSP rats | Q42720323 | ||
| Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study. | Q43241272 | ||
| Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events. | Q43752815 | ||
| Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid | Q43811789 | ||
| Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy | Q43922701 | ||
| Moderate hyperhomocysteinemia provokes dysfunction of cardiovascular autonomic system and liver oxidative stress in rats | Q43998038 | ||
| Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis | Q44016937 | ||
| Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. | Q44103547 | ||
| Coronary artery disease-related genetic variant on chromosome 10q11 is associated with carotid intima-media thickness and atherosclerosis | Q44112175 | ||
| ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins | Q44264415 | ||
| P921 | main subject | folic acid | Q127060 |
| rheumatoid arthritis | Q187255 | ||
| cardiovascular disease | Q389735 | ||
| disease prevention | Q106807541 | ||
| P304 | page(s) | 24 | |
| P577 | publication date | 2015-09-04 | |
| P1433 | published in | Biomarker Research | Q27724844 |
| P1476 | title | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients | |
| P478 | volume | 3 |
| Q52632609 | Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. |
| Q30248838 | Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures |
| Q39524064 | Efficacy of Folic Acid Therapy in Patients with Hyperhomocysteinemia. |
| Q50284988 | Mechanisms of vascular comorbidity in autoimmune diseases. |
| Q40075590 | Targeting methionine cycle as a potential therapeutic strategy for immune disorders. |
| Q60917073 | The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice |
| Q33736457 | Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia |
Search more.